Le Douarin B, vom Baur E, Zechel C, Heery D, Heine M, Vivat V, Gronemeyer H, Losson R, Chambon P
Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, Collège de France, Illkirch, France.
Philos Trans R Soc Lond B Biol Sci. 1996 Apr 29;351(1339):569-78. doi: 10.1098/rstb.1996.0056.
The activity of the ligand-inducible activation function 2 (AF-2) contained in the ligand binding domain (LBD) of nuclear receptors (NRs) is thought to be mediated by transcriptional intermediary factors (TIFs). We have recently reported the isolation and characterization of two novel mouse proteins, designated TIF1 and mSUG1, that interact in a ligand-dependent fashion with the LBD (region E) of several NRs in vivo as well as in vitro. Remarkably, these interactions require the conserved core motif of the AF-2 activating domain (AF-2 AD) and can be blocked by AF-2 antagonists. TIF1 and mSUG1 might therefore represent TIFs/mediators for the ligand-dependent AF-2 of NRs. By comparing the interaction properties of these two putative TIFs with different NRs including the oestrogen (ER), thyroid hormone (TR), vitamin D3 (VDR), retinoic acid (RAR alpha) and retinoid X (RXR) receptors, we demonstrate that: (i) RXR alpha efficiently interacts with TIF1, but not with mSUG1, whereas TR alpha interacts much more efficiently with mSUG1 than with TIF1, and RAR alpha, VDR and ER efficiently interact with both TIF1 and mSUG1; (ii) the amphipathic alpha helix core of AF-2 AD is differentially involved in the interactions of RAR alpha with TIF1 and mSUG1; and (iii) the AF-2 AD cores of RAR alpha and ER are similarly involved in their interaction with TIF1, but not with mSUG1. Thus the interaction interfaces between the various NRs and either TIF1 or mSUG1 may vary depending on the nature of both the receptor and the putative mediator of its AF-2 function. We discuss the possible roles of TIF1 and mSUG1 as mediators of the transcriptional activity of the AF-2 of NRs.
核受体(NRs)配体结合域(LBD)中所含的配体诱导激活功能2(AF-2)的活性被认为是由转录中介因子(TIFs)介导的。我们最近报道了两种新型小鼠蛋白的分离和特性,分别命名为TIF1和mSUG1,它们在体内和体外均以配体依赖的方式与几种NRs的LBD(E区)相互作用。值得注意的是,这些相互作用需要AF-2激活域(AF-2 AD)的保守核心基序,并且可以被AF-2拮抗剂阻断。因此,TIF1和mSUG1可能代表NRs配体依赖型AF-2的TIFs/介质。通过比较这两种假定的TIFs与不同NRs(包括雌激素(ER)、甲状腺激素(TR)、维生素D3(VDR)、视黄酸(RARα)和视黄醇X(RXR)受体)的相互作用特性,我们证明:(i)RXRα与TIF1有效相互作用,但与mSUG1不相互作用,而TRα与mSUG1的相互作用比与TIF1更有效,并且RARα、VDR和ER与TIF1和mSUG1均有效相互作用;(ii)AF-2 AD的两亲性α螺旋核心在RARα与TIF1和mSUG1的相互作用中发挥不同作用;(iii)RARα和ER的AF-2 AD核心在它们与TIF1的相互作用中类似地发挥作用,但与mSUG1的相互作用则不然。因此,各种NRs与TIF1或mSUG1之间的相互作用界面可能因受体及其AF-2功能的假定介质的性质而异。我们讨论了TIF1和mSUG1作为NRs的AF-2转录活性介质的可能作用。